SHARESIFT
Healthcare · data ~15-min delayed
410.35 USD +0.46%
| Price | 410.35 USD |
| Day change | +0.46% |
| Market cap | 59.15B |
| 52-week range | 167.22 – 427.47 |
| P/E (trailing) | — |
| Dividend yield | 0.00% |
| Payout ratio | 0.00% |
| Return on equity | -12.54% |
| Debt / equity | 13% |
| Beta | 1.53 |
| Sector | Healthcare |
| Value score | 21 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Natera, Inc. (NTRA) scores 21/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It is classified in Healthcare. It does not currently pay a dividend. Return on equity is -13%, with debt at 13% of equity. On its filings it passes 3 of the nine Piotroski checks, which points to deteriorating fundamentals. Its Altman Z-Score places it in the safe zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 3 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 74.62 — Safe zone.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: US stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.